These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30133549)

  • 1. Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy.
    Costa HS; Lima MMO; Figueiredo PHS; Martinelli PM; Camargos ER; Chaves AT; Nunes MCP; Rocha MOC
    Mem Inst Oswaldo Cruz; 2018 Aug; 113(10):e180224. PubMed ID: 30133549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure.
    Shibata A; Hanatani A; Izumi Y; Kitada R; Iwata S; Yoshiyama M
    Heart Vessels; 2018 Nov; 33(11):1325-1333. PubMed ID: 29700574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome.
    Kadowaki S; Shishido T; Honda Y; Narumi T; Otaki Y; Kinoshita D; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kubota I
    Heart Vessels; 2016 Apr; 31(4):535-44. PubMed ID: 25616498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different prognostic impact of the tissue Doppler-derived E/e' ratio on mortality in Chagas cardiomyopathy patients with heart failure.
    Nunes MP; Colosimo EA; Reis RC; Barbosa MM; da Silva JL; Barbosa F; Botoni FA; Ribeiro AL; Rocha MO
    J Heart Lung Transplant; 2012 Jun; 31(6):634-41. PubMed ID: 22305956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction.
    Barman HA; Şahin I; Atıcı A; Durmaz E; Yurtseven E; Ikitimur B; Okuyan E; Keleş I
    Anatol J Cardiol; 2019 Nov; 22(6):309-316. PubMed ID: 31789613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of indeterminable anaerobic threshold in heart failure.
    Agostoni P; Corrà U; Cattadori G; Veglia F; Battaia E; La Gioia R; Scardovi AB; Emdin M; Metra M; Sinagra G; Limongelli G; Raimondo R; Re F; Guazzi M; Belardinelli R; Parati G; Magrì D; Fiorentini C; Cicoira M; Salvioni E; Giovannardi M; Mezzani A; Scrutinio D; Di Lenarda A; Mantegazza V; Ricci R; Apostolo A; Iorio A; Paolillo S; Palermo P; Contini M; Vassanelli C; Passino C; Piepoli MF;
    Circ Heart Fail; 2013 Sep; 6(5):977-87. PubMed ID: 23881847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Nadruz W; Gioli-Pereira L; Bernardez-Pereira S; Marcondes-Braga FG; Fernandes-Silva MM; Silvestre OM; Sposito AC; Ribeiro AL; Bacal F; Fernandes F; Krieger JE; Mansur AJ; Pereira AC
    Heart; 2018 Sep; 104(18):1522-1528. PubMed ID: 29523589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum brain-derived neurotropic factor level predicts adverse clinical outcomes in patients with heart failure.
    Fukushima A; Kinugawa S; Homma T; Masaki Y; Furihata T; Yokota T; Matsushima S; Takada S; Kadoguchi T; Oba K; Okita K; Tsutsui H
    J Card Fail; 2015 Apr; 21(4):300-6. PubMed ID: 25639689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular diastolic function and exercise capacity in patients with Chagas cardiomyopathy.
    Lima MM; Nunes MC; Rocha MO; Beloti FR; Alencar MC; Ribeiro AL
    Echocardiography; 2010 May; 27(5):519-24. PubMed ID: 20412275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure.
    Florea VG; Henein MY; Anker SD; Francis DP; Chambers JS; Ponikowski P; Coats AJ
    Eur Heart J; 2000 Jan; 21(2):146-53. PubMed ID: 10637088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of the Incremental Shuttle Walk Test in Chagas cardiomyopathy.
    Ávila MR; Figueiredo PHS; Lima VP; de Oliveira LFL; de Oliveira LFF; Silva WT; Trede Filho RG; de Carvalho Bastone A; Lacerda ACR; Mendonça VA; Mediano MFF; Costa HS
    Disabil Rehabil; 2022 Dec; 44(24):7516-7521. PubMed ID: 34613873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical training improves exercise tolerance, cardiac function and promotes changes in neurotrophins levels in chagasic mice.
    Alves RL; Cardoso BRL; Ramos IPR; Oliveira BDS; Dos Santos ML; de Miranda AS; de Almeida TCS; Vieira MAR; Machado FS; Ferreira AJ; de Avelar GF
    Life Sci; 2019 Sep; 232():116629. PubMed ID: 31276687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
    Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study.
    Nunes MC; Barbosa MM; Ribeiro AL; Barbosa FB; Rocha MO
    J Neurol Sci; 2009 Mar; 278(1-2):96-101. PubMed ID: 19162278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
    Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
    Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor.
    Pereira Nunes Mdo C; Barbosa MM; Ribeiro AL; Amorim Fenelon LM; Rocha MO
    Rev Esp Cardiol; 2010 Jul; 63(7):788-97. PubMed ID: 20609312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy.
    Nunes MC; Barbosa MM; Ribeiro AL; Colosimo EA; Rocha MO
    J Am Soc Echocardiogr; 2009 Jan; 22(1):82-8. PubMed ID: 19131007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors in Severe Chagasic Heart Failure.
    Costa SA; Rassi S; Freitas EMDM; Gutierrez NDS; Boaventura FM; Sampaio LPDC; Silva JBM
    Arq Bras Cardiol; 2017 Mar; 108(3):246-254. PubMed ID: 28443956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.
    Freitas HF; Chizzola PR; Paes AT; Lima AC; Mansur AJ
    Int J Cardiol; 2005 Jul; 102(2):239-47. PubMed ID: 15982491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.